Merck & Co., Inc.
- MRK
- NYSE
- Drug manufacturers
- Pharmaceuticals (Oncology)
- Animal Health
$148.09
Today +3.10%Quote Oct 20, 2026, 02:55 PM UTC
−2.13%over the last month
Max drawdown −7.5%From 1-month high −4.8%3 months +13.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Merck
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products.
Where the money comes from
Q2 2026 revenue $16.61B
- Pharmaceutical segment$14.76B88.9%
- Animal Health segment$1.77B10.7%
Sector
Healthcare
Industry
Drug manufacturers
Exchange
NYSE
Employees
74,000
Market value
$365.35B
Quote Oct 20
Floor
$146.22
1.3% below price
Resistance
$151.51
2.3% above price
Price vs analyst targets
38 analysts
Lowest target
$105.00Highest target
$180.00
$105.00Highest target
$180.00
- Price $148.09
- Average target $158.22
- Analysts' target range
Analysts' average target sits about 7% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MRKPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free